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Abstract
Upon exposure to shaking stress, an IgG1 mAb formulation in both liquid and lyophilized state 
formed subvisible particles. Since freeze-drying is expected to minimize protein physical 
instability under these conditions, the extent and nature of aggregate formation in the lyophilized 
preparation was examined using a variety of particle characterization techniques. The effect of 
formulation variables such as residual moisture content, reconstitution rate, and reconstitution 
medium were examined. Upon reconstitution of shake-stressed lyophilized mAb, differences in 
protein particle size and number were observed by Microflow Digital Imaging (MFI), with the 
reconstitution medium having the largest impact. Shake-stress had minor effects on the structure 
of protein within the particles as shown by SDS-PAGE and FTIR analysis. The lyophilized mAb 
was shake-stressed to different extents and stored for 3 months at different temperatures. Both 
extent of cake collapse and storage temperature affected the physical stability of the shake-stressed 
lyophilized mAb upon subsequent storage. These findings demonstrate that physical degradation 
upon shaking of a lyophilized IgG1 mAb formulation includes not only cake breakage, but also 
results in an increase in subvisible particles and turbidity upon reconstitution. The shaking-
induced cake breakage of the lyophilized IgG1 mAb formulation also resulted in decreased 
physical stability upon storage.
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When a protein therapeutic is appropriately lyophilized with stabilizing excipients, the solid 
dosage form typically displays increased physicochemical stability during storage and 
shipping, compared to a liquid formulation counterpart, resulting in a longer shelf life 
including a lower propensity toward aggregation.1-3 Many proteins, including monoclonal 
antibodies (mAbs), have been shown to be more stable during exposure to elevated 
temperatures in the lyophilized than in the liquid state1,4-7, although there are some 
exceptions to this general rule.6 Despite protein lyophilization being a relatively well-
established formulation technology, there remains numerous challenges both in terms of 
developing an improved understanding of protein degradation pathways in the solid state as 
well as better optimizing lyophilization process design and scale-up 1,5,8,9.
The lyophilization process typically consists of freezing, primary and secondary drying, and 
reconstitution steps, each of which may structurally damage proteins10-14. Freezing of bulk 
water in a protein solution can cause cryoconcentration of protein and excipients, pH 
changes, and/or adsorption of protein to the surface of ice crystals10,13,14. Primary drying 
removes the frozen bulk water and further concentrates the protein and stabilizers, allowing 
the possibility of unfavorable interactions 5,11. Protein instability is also possible during 
secondary drying, during which the non-frozen water bound to the protein or excipients is 
removed. The composition of the reconstitution medium and it's rate of addition may also 
affect the stability of a lyophilized protein upon reconstitution back into the liquid state15. 
For example, if the reconstitution medium is added too rapidly, the dried protein may not be 
given sufficient time to rehydrate and assume its native conformation, and the presence of 
this improperly rehydrated protein may lead to aggregation. 6,16. The aggregation of 
monoclonal antibodies in the lyophilized state, and/or upon reconstitution, has also been 
correlated with formation of non-native intermolecular disulfide bonds17 as well as the 
appearance of aggregates of different sizes including an increased number of subvisible 
particles18.
A freeze-dried cake's physical structure and moisture level are typically optimized as part of 
protein lyophilization development, since either can potentially affect the extent to which a 
protein may aggregate in the solid state 6,19-21. These parameters can be interrelated since 
changes in residual moisture content may affect not only protein structure, but also the 
physical integrity of the lyophilized cake itself (i.e., a change from a viscous to a rubbery 
state where molecular mobility increases7). Some lyophilized protein preparations with high 
moisture content have shown increased chemical degradation due to increased mobility and 
the ability of water to participate in chemical reactions.22,23 However, a bell shaped 
relationship between moisture content and physical stability (aggregation) has also been 
observed, e.g., lyophilized recombinant human albumin displayed maximum aggregation at 
∼50% moisture content. 24 In terms of the effect of the physical integrity of a freeze-dried 
cake on protein stability, it has been shown that when a lyophilized cake of an IgG1 mAb is 
physically collapsed to different extents by using different amounts of stabilizers and 
bulking agents during the freeze-drying process, the mAb can still remain stable in the 
different preparations.19-21 The method of cake collapse, however, either during the freeze-
Telikepalli et al. Page 2






















drying cycle or during storage at elevated temperatures, has been shown to potentially be an 
important factor in determining protein stability during subsequent storage.21
The effect of mechanical stress on the stability of lyophilized proteins has not been as 
widely examined. In this work, to examine the potential of shipping stress to cause protein 
aggregation, we implemented a stress shipping test based on considering guidelines in the 
vibration testing document D999 proposed by ASTM International Standard Test Methods 
for Vibration Testing of Shipping Containers25. Currently, there are no guidance documents 
available that are specific for pharmaceutical products that outline the testing criteria to use 
when evaluating product quality impact of shipping-related stress. Initially, we examined the 
physical stability of an IgG1 mAb formulation in both a liquid and lyophilized state after 
exposure to shaking stress with the expectation that the protein in the lyophilized state 
would be more stable in terms of aggregation and particle formation. Surprisingly, the 
lyophilized preparation also displayed mAb physical instability (upon reconstitution).
The focus of this work was to better understand the effect of shaking stress, used to mimic 
extreme shipping conditions, on the physical stability of a lyophilized mAb preparation. A 
wide variety of analytical characterization techniques were used to size and count protein 
aggregates and particles across a wide size range including size-exclusion chromatography 
(SEC), dynamic light scattering (DLS), Nanoparticle Tracking Analysis (NTA), Resonant 
Mass Measurement (Archimedes), Microflow-Imaging (MFI), and turbidity. We also used 
data visualization tools (e.g., radar plots) to display and compare the number and size of 
protein particles formed under different conditions. The composition of the protein found in 
particles was further examined using SDS-PAGE and FTIR Microscopy. We determined 
how formulation variables such as residual moisture content, reconstitution speed, and 
composition of the reconstitution medium affected the formation of subvisible particles and 
solution turbidity when the lyophilized mAb was exposed not only to shaking stress, but also 
to subsequent storage for three months at various temperatures.
Materials and Methods
Materials
Lyophilized IgG1 mAb samples prepared at 0.6% and 6.8% moisture content, and their 
corresponding matching placebos without protein, were supplied in stoppered 20 mL glass 
vials by Human Genome Sciences (currently GlaxoSmithKline). Upon reconstitution with 5 
mL of deionized water from Water Pro PS Station (Labconco, Kansas City, MO), the target 
concentration was approximately 30 mg/mL protein, in a formulation consisting of 0.08 
mg/mL citric acid monohydrate (Avantor Performance Materials, JT Baker 0115, Center 
Valley, PA), 1.6 mg/mL sodium citrate dihydrate (Avantor Performance Materials, JT Baker 
3647), 11 mg/mL glycine (Avantor Performance Materials, JT Baker 0581), 3 mg/mL 
sucrose (Avantor Performance Materials, JT Baker 4005), and 0.12 mg/mL polysorbate-80 
(Croda International, SR48833, England) at pH 6.5. Lyophilized samples were stored at 4 
°C unless otherwise indicated. The IgG1 mAb has a pI of ∼8.4 and protein concentrations 
were determined by UV spectroscopy at 280 nm with an extinction coefficient of ε 0.1% 
=1.58 (g/100mL)-1 cm-1.
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Shaking stress studies—Glass vials containing lyophilized and liquid IgG1 protein 
samples and corresponding placebo controls were taped horizontally inside of a lightweight, 
cryogenic box (13 × 13 × 5 cm), which was then taped to the cuphead of a 4.9 mm orbit 
Fisher Scientific Analog Vortex Mixer (Waltham, MA) and shaken vigorously at 3200 rpm 
for different periods of times at ambient temperature. Depending on the experiment, the 
shake-stressed samples were either in the lyophilized (solid) state or in the reconstituted 
(liquid) state. Unstressed and stressed samples of lyophilized protein and placebos were 
reconstituted with 5 mL of deionized water (Labconco) over 10 s, unless otherwise noted. 
To prepare the liquid samples, the lyophilized protein formulation was reconstituted with 5 
mL of deionized water (Labconco) prior to shaking.
To study the effect of reconstitution medium type and addition rate, shake-stressed (for 24 h) 
and unstressed lyophilized IgG1 mAb samples were reconstituted by adding 5 mL of four 
different diluents (deionized water, 150 mM NaCl, 150 mM NaCl + 0.05% polysorbate 80, 
and 500 mM NaCl) at two rates (5 mL injected over 10 s and 5 mL injected over 2.5 min). 
To study the effect of shake-stress on subsequent storage stability, lyophilized mAb samples 
in stoppered glass vials were shaken for 2.5 min or 24 h and placed at 4, 40, or 55°C for up 
to 3 months at ambient humidity. Intact, unstressed samples (no cake breakage) were also 
stored up to 3 months at these temperatures. At time zero in the stability study, intact cake 
samples, 2.5 min shaking, and 24 h shaking samples were analyzed immediately (no 
storage). Placebos were also analyzed after 3 months storage at 55°C.
Turbidity—To monitor solution turbidity of samples, a HACH 2100 AN turbidimeter 
(HACH, Loveland, CO) was used. Prior to analyzing the experimental samples, StableCal 
calibration standards (Hach, Loveland, CO), ranging from <0.1 to 4000 Nephelometric 
Turbidity Units (NTU), containing hexamethylenetetramine and demineralized water, were 
used for generating a standard curve. The method is based on comparing intensity of light 
scattered by a sample under defined conditions with the intensity of light scattered by a 
standard reference suspension. Samples were not centrifuged or diluted for analysis.
Size-exclusion HPLC (SE-HPLC)—A Shimadzu UFLC HPLC system equipped with a 
diode-array detector and a Tosoh Bioscience (Tokyo, Japan) TSK-Gel G3000SWXL (7.8 
mm ID × 30.0 cm, 5μm) and the corresponding guard column (TSK-Gel Guard Column 
SWXL, 6.0 mm ID × 4.0 cm, 7μm) were used to monitor for the presence of soluble 
aggregates (< 100 nm). Prior to sample runs, the columns were rinsed for 60 min with 
deionized water followed by equilibration at 30°C for 1 h using mobile phase (10 mM 
sodium phosphate, 450 mM sodium chloride, pH 7.4) at a flow rate of 0.5 ml/min. 
Molecular weight standards (Biorad Laboratories, Hercules, CA) were run to test for 
efficacy of separation and resolution. Samples were centrifuged at 16,000 × g for 5 min and 
10μL of supernatant was injected for analysis and monitored at 280 nm for each 35 min 
sample run. Aggregates, monomers, and fragment peaks were quantified using the LC 
Solutions data analysis software provided with the instrument.
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Nanoparticle Tracking Analysis—Submicron sized particles (50-1000 nm) were 
measured using a Nanosight LM-14 (Nanosight, Amesbury, UK) with a CCD camera. 
Stressed samples and controls were centrifuged at 16,000 × g for 5 min, to separate larger 
aggregates outside the instrument sizing range. The supernatant was diluted 100 fold in 
formulation buffer (η=1.08 mpa. S for formulation buffer and η=1.36 mpa. S for the 
unstressed sample). Three hundred microliters of the 100 fold diluted supernatants were 
injected into the sample holder. Three 30 s movies were taken at ambient temperature for 
each sample. All samples were corrected for dilution. Data analysis was performed using the 
NTA 2.3 software, provided with the instrument, with detection threshold of 16, a screen 
gain of 7, and a minimum expected particle size of 50 nm.
Dynamic Light Scattering (DLS)—DLS measurements were performed to monitor 
small nanometer sized particles (1-1000nm) using a DynaPro™ Plate Reader (Wyatt 
Technologies, Santa Barbara, CA). Prior to analysis, the protein samples and controls were 
centrifuged at 16,000 × g for 5 min to remove large aggregates. The supernatant was 
separated and 30μL of the supernatant was loaded into a clear bottom 384 well assay plate 
(Corning Incorporated, Corning, NY). The plate was then centrifuged at 1177 × g for 3 min 
to remove air bubbles. Measurements were performed at 20°C with auto attenuation using 
the globular protein model and with the viscosity values determined using an Anton Parr 
Stabinger Viscometer 3000 (Anton Parr Inc., Ashland, VA). The data were collected using 
the Dynamics V 7.1.6 software, provided with the instrument, and analyzed using 
multimodal analysis.
Resonant Mass Measurements—Analysis of 0.25 to 3 micron sized particles was 
accomplished using an Archimedes particle metrology system (Affinity Biosciences, Santa 
Barbara, California). The instrument was first calibrated with NIST standard 1 μm 
polystyrene beads prior to analyzing experimental samples. To prevent clogging of the Hi-Q 
micro sensors, samples were centrifuged at 16,000 × g for 5 min and supernatants were 
analyzed. Triplicates of each sample were allowed to run until 500 particles were counted to 
obtain statistically significant data. Particle Lab software, provided with the instrument, was 
used to obtain particle size and concentration.
Micro-flow Digital Imaging and Radar Chart Analysis—Micron sized subvisible 
particles (2-100 μm) were analyzed and imaged using an MFI DPA-4200 (Protein Simple, 
Santa Clara, CA). See the method described in Telikepalli et al. 201426 for further details. 
Protein containing samples were diluted 100 fold prior to analysis and this dilution factor 
was accounted to determine particle concentration. MFI's MVAS 1.3 software was used to 
collect particle imaging data, which was then analyzed by radar plots to assess the particle 
size and concentration distribution for the unstressed and stressed samples using in-house 
software (Middaugh Suite) as described in detail elsewhere26-28. Additional radar plot 
analysis was performed in which the particle concentrations in each size bin for the stressed 
samples were normalized relative to its “control,” an unstressed sample that is similar in all 
other parameters. This normalization helps in visualizing and rank ordering the relative 
impact of a particular formulation parameter (e.g., stress) on the relative extent and size 
distribution of particle formation.
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SDS-PAGE—Samples were mixed with 4× NuPAGE LDS sample buffer (Life 
Technologies, Carlsbad, CA) with and without, 50mM dithiothreitol (BioRad Laboratories, 
Hercules, CA) and incubated at 80°C for 90 s. Approximately 10 μg of each sample was 
separated on a 3-8% Tris-Acetate gel using Tris-Acetate Buffer (Life Technologies, 
Carlsbad, CA). Hi-Mark Unstained Protein Standard (Life Technologies, Carlsbad, CA) was 
used as a molecular weight ladder. Protein bands were visualized by staining the gels with 
Bio-safe Coomassie Blue G250 stain (BioRad Laboratories, Hercules, CA).
FTIR—Unstressed lyophilized mAb, after being reconstituted with 5 mL deionized water 
over 10 s, was analyzed for overall secondary structure content as a function of temperature 
by Fourier transform infrared spectroscopy (FTIR) using instrumentation and methodology 
presented in Telikepalli et al. 201426.
FTIR Microscopy-15× Objective-Reflectance mode—The method from Telikepalli 
et al. 201426 was used to prepare and isolate protein particles from stressed samples, and 
then to perform overall secondary structure analysis of proteins within individual isolated 
particles using a Bruker Hyperion FTIR Microscope (Bruker Biosciences, Billerica, MA) 
with a 15× objective in reflectance mode to image individual particles on gold coated filters 
(Pall Corporation, Port Washington, NY).
Results
Comparison of the physical stability of an IgG1 mAb formulation in the solid and liquid 
state during shaking
Samples of the IgG1 mAb were shaken (to simulate extreme shipping stress conditions) in 
the same formulation in the liquid or solid state for 5 min, 2h, 6h, and 15 h. Upon shaking, 
the solid state lyophilized cake increasingly turned into a finer, broken down powder after 
each of these shaking conditions. The physical stability of the mAb was assessed by a 
combination of analytical techniques including SE-HPLC, DLS, NTA, MFI, and turbidity. 
These techniques were used to determine differences in the aggregation behavior of protein 
from lyophilized and liquid shake-stressed samples across a wide aggregate size range of 
nanometers to hundreds of microns29. Aggregate formation in the size range of 1-1000 nm 
(detectable by a combination of SE-HPLC, DLS, and NTA) was minimal with similar 
results in both types of stressed samples (data not shown). For example, with SE-HPLC, 
approximately 99% monomer and 1% aggregate was noted at time zero with no change after 
shake-stress. Additionally, no changes in the total area of the SEC peaks were observed, 
suggesting no detectable change in the total protein concentration by this method. DLS 
showed predominantly monomers (approximately 5 nm radius), with no changes in 
hydrodynamic size of protein in these samples after shake-stress. For NTA analysis, 
submicron sized particles in the range of 100-300 nm were observed in the samples with no 
changes noted in particle concentration and size distribution as a function of shake-stress 
(data not shown).
In contrast, differences in solution turbidity and micron size particle concentrations 
(detected by MFI) were observed between the liquid and lyophilized mAb samples after 
shaking as shown in Figure 1A and 1B, respectively. The turbidity of the liquid sample does 
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not appear to change even after 15 h of shaking. In contrast, for the lyophilized sample, the 
turbidity of the solution (upon reconstitution) increases as a function of shaking time (Figure 
1A). After stressing the liquid and lyophilized samples for 5 min up to 15 h, the liquid and 
lyophilized samples both showed a small increase in the total number of micron sized 
particles as measured by MFI (Figure 1B). Given the variability in the particle concentration 
determinations, it was concluded that both the liquid and lyophilized stressed samples 
generated similar levels of micron particles, with the 15 h time point showing a trend such 
that the lyophilized stressed sample may actually produce a greater number of micron sized 
particles than the liquid stressed samples.
The relative instability of the lyophilized protein was not anticipated. In fact, it was assumed 
that the protein in liquid state would be more susceptible to physical degradation by shaking, 
compared to the lyophilized state, even though the formulation contained polysorbate 80, a 
non-ionic surfactant which is known to stabilize against shaking-induced degradation in 
liquid formulations. To better understand these observations, a series of experiments were 
performed as described below to examine the effect of shaking the lyophilized formulation 
on the physical stability of the IgG1 mAb (measured upon reconstitution) as determined by 
solution turbidity and formation of micron sized particles (MFI).
Characterization of particle formation in shake stressed lyophilized mAb samples
In an initial set of experiments, the effect of moisture content on the physical stability of the 
lyophilized mAb after shaking was assessed. Both “low” moisture (0.6%) and “high” 
moisture (6.8%) freeze-dried samples were prepared and then shaken for 24 h, turning both 
lyophilized samples into broken apart, finer powders, prior to reconstitution. No increases in 
size or in concentration of soluble aggregates or submicron particles were observed as a 
function of stress or moisture content by SE-HPLC and NTA, respectively (data not shown). 
In addition, DLS analysis did not show the presence of species other than the monomer 
across the four samples (data not shown). Twenty-four hours of shaking increased the 
solution turbidity and micron sized particle counts for both samples (Figure 2). The shake-
stressed 6.8% moisture lyophilized mAb sample showed somewhat increased levels of 
turbidity and particle counts when compared to the 0.6% moisture samples.
The MFI total particle concentration data displayed in Figure 2 were further analyzed and 
displayed as a radar chart to better visualize the particle size distributions in the four samples 
as shown in Figure 3. Two different scales, shown on the right side of the figure, are used to 
analyze these MFI data. The “particle number” scale, used to display the actual MFI particle 
size and concentration data for samples at time 0 and after 24 hours of shaking, has the 
innermost circle representing the lowest particle concentration of ∼0 particles/mL and the 
outermost corresponding to the highest concentration of ∼2.5 × 106 particles /mL. The 2-5 
μm size bin starts at the top and increases clockwise up to a 25-40 μm size bin. The 
“normalized” scale shows particle concentrations of the stressed sample relative to its 
unstressed control for each size bin. Thus the scale increases from 0× (innermost circle) to 
50× (outermost circle), where the latter indicates the number of particles in a size bin after 
shake-stressing are 50× greater than the number of particles in the same size bin at time 0 
(no shaking).
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For both the low and high moisture samples, the lyophilized mAb shows a low number of 
micron-sized particles upon reconstitution. After 24 h of shaking, the number of 2-5 μm 
particles increased (along with a small increase in 5-10 μm particles) in both moisture level 
samples. However, the 6.8% moisture samples formed more 2-5 μm particles than the 0.6% 
samples after shaking. This effect is more clearly reflected in the normalized radar plots 
where, it can be seen that the shake-stressed 6.8% moisture sample shows a larger relative 
increase in particles compared to its control than the shake-stressed 0.6% moisture sample. 
For example, there is an ∼40 fold increase in the formation of 2-5 μm particles compared to 
the unstressed control for the 6.8% moisture sample, but only about a 10 fold increase of the 
2-5 μm for the shaken 0.6% moisture sample. Similarly, a larger relative increase is 
observed for the formation of 5-10 μm sized particles, with an almost 35 fold increase for 
the higher moisture sample after shaking.
In addition to sizing and counting particles, the nature of the protein within the particles 
formed was examined by SDS-PAGE and FTIR analysis. In both the control and shake-
stressed lyophilized samples at the two different moisture levels, non-reduced and reduced 
SDS-PAGE gels were compared. In the non-reduced gel, mostly IgG1 monomers with some 
fragments and dimers were observed. Upon reduction with dithiothreitol, however, dimers 
were reduced and only heavy and light chains of the IgG1 can be seen (see Supplemental 
Figure S1). However, it appeared that these dimers were not forming as a function of the 
shake-stress and were present in all of the samples. Additionally, upon centrifugation of 
samples into supernatant and pellet components, no notable differences were seen in both 
the non-reduced and reduced SDS-PAGE gels for the supernatant, pellet, or the non-
centrifuged samples.
FTIR and FTIR Microscopy were used for the evaluation of overall secondary structure of 
the mAb in solution and of the mAb within the particles formed as a function of shaking 
stress in the lyophilized samples, respectively. Representative FTIR spectra, and 
corresponding wavenumber positions from triplicate measurements, are shown for two 
control samples and for the 0.6% and 6.8% moisture lyophilized mAb samples in Figures 
4A and 4B, respectively. The solid black line corresponds to the FTIR second derivative 
spectrum of the Amide I band of the unstressed, control mAb in solution and shows spectra 
with minima around 1636 and 1690 cm-1, which correspond to the intramolecular beta 
sheets that are in the main secondary structure of antibodies. To determine the extent of 
secondary structure loss that is possible with this mAb, the mAb solution was extensively 
heated and the resulting isolated particles were analyzed by FTIR Microscopy. The second 
derivative spectra, depicted as blue dotted graphs, possess minima at 1622 cm-1 and 1619 
cm-1 and 1692 cm-1 and 1693 cm-1 indicating loss of intra-molecular beta sheets and 
formation of inter-molecular beta sheets (i.e., aggregation). The red dotted lines are the 
second derivative spectra of the isolated protein particles obtained from each of the two 
shake-stressed samples by FTIR Microscopy (after reconstitution of the low and high 
moisture lyophilized mAb samples followed by filtration and capture of particles on a gold 
filter). Compared to the two control samples (unstressed sample in solution and heat 
control), the IgG1 in the protein particle from the T=24 h shake-stressed sample has similar 
overall secondary structure to the unstressed control. However, these isolated protein 
particles may have a slightly altered overall secondary structure content compared to the 
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protein in the unstressed sample since their spectra show a small shift in the average minima 
around 1633 cm-1 and 1691 cm-1. Importantly, the particles obtained from the 0.6 and 6.8% 
moisture samples showed similar levels of change in protein secondary structure indicating 
that for this IgG1 mAb, moisture content in conjunction with shake stress do not seem to 
largely impact the secondary structure of the protein within the particles.
Characterization of particle formation in shake stressed lyophilized mAb samples as 
function of reconstitution medium type and addition time
For both the low and high moisture containing lyophilized mAb samples, the control 
(unstressed) vials fully reconstituted in about 30 s, while the shake-stressed vials took ∼ 1.5 
min. This was similar regardless of the medium type or medium addition rate. There was no 
difference in reconstitution time as a result of moisture content, so the effect of medium type 
and addition rate were further examined with the low moisture lyophilized sample. The 
0.6% moisture lyophilized sample was shaken for 24 h and reconstituted with 5 mL of 
different mediums at two different rates and then monitored for their effects on physical 
stability of the mAb by measuring solution turbidity and the concentration of micron-sized 
particles. As shown in Figures 5A and 5B, the shake stressed lyophilized samples were more 
turbid and contained higher concentrations of micron-sized particles than the non-shaken 
samples upon reconstitution. Reconstitution with water consistently led to higher solution 
turbidity and higher micron-sized particle concentrations than reconstitution with the other 
diluents. In addition, the role of medium addition rate was examined and no effects were 
observed for most of the conditions with two exceptions: (1) for the 24 h shake-stressed 
lyophilized samples reconstituted at a slow rate with 150 mM NaCl + 0.05% polysorbate 80, 
higher turbidity and increased particle counts were observed compared to the fast addition of 
this medium, and (2) while the turbidity did not change, reconstituting the shake-stressed 
lyophilized sample slowly with 150 mM NaCl solution produced more micron-sized 
particles than the same sample reconstituted at the fast rate.
Radar plot analysis of the MFI particle data showed some distinct relative changes in 
particle size distribution depending on the medium selection and the rate of addition 
(Figures 6 for water as the medium and Figure 7 for the other diluents; note the scale 
differences in the two figures). Regardless of medium type, predominantly 2-5 μm particles 
are formed upon shake-stress lyophilized samples upon both the slow and fast medium 
addition. When water was used as the reconstitution medium (Figure 6), there was almost a 
15 fold increase in the formation of 5-10 μm particles upon slow reconstitution compared to 
the unstressed sample similarly reconstituted. In contrast, rapid addition of water resulted in 
a smaller relative increase in particles formed in this same size range. For the other medium 
types, the addition rate was found to have some effect on the micron particle concentration 
as shown in Figure 7. Slow reconstitution of the shake-stressed lyophilized samples with 
150 mM NaCl and 150 mM NaCl+0.05% polysorbate 80 produced a larger relative increase 
(as seen by the normalized plot) in the formation of micron particles across the size bins. 
Such a relative increase in particle formation was not observed upon more rapid addition of 
these reconstitution media.
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Effect of shake stressing lyophilized mAb samples on subsequent storage stability
A three month stability study was performed using the lyophilized mAb samples (0.6% 
moisture) after exposure to different amounts of shake stress. Intact lyophilized cakes 
(unstressed controls), slightly broken cakes (shaken for 2.5 min) and completely broken 
lyophilized cakes (shaken for 24 h) were stored at 4, 40, and 55°C for 3 months (at ambient 
humidity) in stoppered glass vials. Representative pictures of the physical integrity of these 
lyophilized cakes corresponding to the varying levels of shake stress are shown in Figure 
8A. Upon fast addition with 5 mL deionized water, samples were analyzed by a combination 
of NTA, MFI, and turbidity. NTA showed no changes in aggregation due to stress (data not 
shown). In contrast, solution turbidity (Figure 8A) and micron-sized particles measured by 
MFI (Figure 8B) did reveal some stability differences as a function of shake stress and 
storage temperature (in addition, at the higher temperatures and longer time periods, slight 
yellow color changes were noted in all of the samples upon reconstitution; data not shown). 
As shown in Figure 8A, all samples showed an increase in turbidity with increasing storage 
temperature (4°C < 40°C < 55°C). If samples stored for identical time periods are 
considered, turbidity did not significantly increase in the intact and 2.5 min shaken samples. 
The samples stored at 55°C were the most turbid, followed by the samples stored at 40°C 
(4°C < 40°C < 55°C). Figures 8C and 8D show normalized turbidity and normalized micron 
particle concentrations obtained by taking a ratio of turbidity (or micron particle 
concentration) of the stressed sample to its control (T=0) for a given shaking duration. This 
shows the change in turbidity or number of micron particles in a sample relative to its 
unstressed control. At 40°C, after three months of storage, the relative change in turbidity 
and total subvisible particle concentration for all shaken samples is approximately 1.5× and 
2-3×, respectively. At 55°C after three months, the relative change for the shaken samples is 
about 3.5-5× and 7-15× for turbidity and total micron particle concentration, respectively.
In summary, Figures 8A and 8B show increasing turbidity and particle counts with 
increasing shaking duration, storage time, and temperature. However, the T=0 samples 
themselves show an increase in turbidity and micron sized particle counts with increasing 
shaking duration (T=0 Intact cake < T=0 2.5 min shaking < T=0 24 h shaking). Higher 
temperatures and longer storage show an increase in turbidity and particle counts relative to 
the control (4°C < 40°C < 55°C and T=0 ∼ T=1 month < T=3 months) within each shaking 
time. When different shaking times are compared, in terms of relative changes versus time 
zero (Figures 8C and 8D), however, both relative turbidity and relative micron particle 
concentration changes stay constant or even decrease, especially for the samples stored at 
55°C for three months as the cake structure is increasingly collapsed.
Discussion
The focus of this work was to better characterize how shaking of a freeze-dried IgG1 mAb 
formulation can affect protein stability upon reconstitution. We first examined the 
lyophilized IgG1 mAb control (no shake-stress), which showed minimal levels of physical 
instability after reconstitution. These initial results indicated the formulation composition 
and lyophilization cycle resulted in a stable protein preparation. While there is a plethora of 
literature on how to effectively formulate and stabilize protein drugs during the 
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lyophilization process and subsequent long term storage,1,5,17,24,35 the effect of subsequent 
mechanical stresses applied to the lyophilized dosage form on physical stability and 
aggregation of mAb, which could potentially occur during shipping and handling, has not 
been examined to the same extent.
Physical Stability of Shake-stressed mAb in Lyophilized State
In this work, mechanical shaking-stress was applied to the liquid and lyophilized state of an 
IgG1 mAb formulation, and a variety of analytical techniques were used to assess the 
physical stability of the mAb. These results highlight the need to examine protein 
aggregation across a wide size range since no one analytical approach covers the different 
size ranges of protein aggregates and particles that may form26,29,36. SEC and DLS, two 
very commonly used techniques to monitor soluble, nanometer sized aggregates, along with 
NTA, to detect submicron sized particles, showed no differences in particle levels between 
control (unstressed) and shake-stressed samples across the various experiments. 
Interestingly, although the shaking stress had minimal effects on the formation of soluble 
aggregates and smaller submicron sized particles, physical instability was detected by 
turbidity measurements and by formation of larger micron size particles (as shown by MFI). 
Thus, shake-stressing the lyophilized mAb, followed by reconstitution, led to increased 
levels of protein particles in the subvisible size range (∼2-100 microns) but not in the 
smaller, submicron size ranges. These results highlight the need to examine protein 
aggregation across a wide size range since no one analytical approach covers the different 
size ranges of protein aggregates and particles that may form26,29,36
The shake-stress had minor effects on the conformation and composition of the protein 
contained within these particles as evidenced by SDS-PAGE and FTIR analysis. Upon shake 
stressing freeze-dried cakes, the resulting protein particles, formed in two different moisture 
level samples, showed similar levels of non-native disulfide crosslinks (SDS-PAGE) and the 
presence of slightly altered overall secondary structure content compared to the native 
protein (FTIR analysis). In contrast, the role of non-native disulfide bond formation in the 
generation of aggregates appears less influential than has been observed previously with 
other lyophilized mAbs17. A recent study performed in our laboratory studied the 
aggregation behavior of a mAb undergoing shaking stress. While this was a different IgG1 
mAb, in a liquid solution and in a different formulation, shake stress also led to formation of 
particles with only minor changes in overall conformational integrity of the protein within 
the particles as seen by SDS-PAGE, FTIR and by ANS fluorescence spectroscopy26.
The effect of the residual moisture content of the lyophilized cake on the physical stability 
of the mAb after shake-stress was also evaluated. There is an abundance of literature 
describing the effects of moisture content on the stability of lyophilized protein 
therapeutics19-22 Improved protein stability is often observed at lower moisture contents of a 
lyophilized cake, with values not exceeding 2.0% 6, however, exceptions have been noted. 
For example, when the stability of a lyophilized humanized mAb produced with varying 
moisture contents and stored at elevated temperatures up to a year was analyzed,22 no cake 
collapse or changes in protein secondary structure were observed22 but the intermediate 
moisture level samples were more resistant to aggregation. The relationship between 
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moisture content and protein aggregation potential is complex and may be very dependent 
on the protein itself, formulation composition and freeze-drying conditions1,5-7,22. In our 
study with an IgG1 mAb, the physical stability of the 6.8% moisture sample was not 
drastically different than the 0.6% moisture sample during lyophilization or upon exposure 
to subsequent mechanical stress.
Effect of Reconstitution on Shake-Stressed Degradation of Lyophilized mAb
The choice of medium used to reconstitute the lyophilized IgG mAb was an important factor 
in this study6,37. Using water as the diluent for both the unstressed and shake-stressed 
lyophilized mAb samples resulted in higher solution turbidity, and in an increased 
concentration of micron sized particles, compared to the use of other diluents. The addition 
of sodium chloride solutions partially inhibited the formation of micron particles in our 
studies probably because the sodium chloride reduces protein-protein colloidal 
interactions.638 Previous studies have shown the importance of ionic strength in 
reconstitution solutions where either increased or decreased ionic strength of the 
reconstitution medium inhibited protein aggregation, highlighting the protein and 
formulation specific nature of these observations. 33,37-40 However, sodium chloride 
containing diluents result in reconstituted mAb solutions with higher solution osmolality, 
which might be a concern depending on the route of administration (e.g., subcutaneous 
injection into the patient). The presence of polysorbate 80 in the reconstitution buffer 
perhaps had a small stabilizing effect on the formation of subvisible particles upon 
reconstitution. Numerous studies have shown that polysorbate can decrease aggregation 
when used in the reconstitution medium38,39,41-43. It has been suggested that surfactants 
may increase wettability of powders leading to increased dissolution rate of lyophilized 
powders, inhibit surface induced denaturation during reconstitution, or stabilize the native 
state of the protein by increasing the free energy of unfolding. 39,41,43 Stabilizing 
compounds, such as polysorbate 80 or NaCl, in the diluent may prevent or reduce protein-
protein interactions, and/or the physical dilution imparted by their addition can lead to 
separation of protein molecules and hinder aggregation7.
Upon reconstitution, the type of diluent and the rate of diluent addition can affect not only 
protein stability, 6,40 but also reconstitution times. The rate of diluent addition on the 
physical stability of the reconstituted, lyophilized IgG1 mAb in this study was, in general, 
not an important factor. However, the time required for reconstitution was longer for the 
shake-stressed lyophilized samples than the unstressed vials (approx. 0.5 vs. 1.5 minutes), 
regardless of the rate of addition or the type of diluent used. Since the physical state of the 
lyophilized mAb impacts dissolution time upon reconstitution, it is possible this results in 
differences in local protein or excipient concentrations and subsequently to the observed 
differences in subvisible particle formation. The higher surface area and porosity present in 
the lyophilized cake, compared to the finer powder formed after shaking, may allow it to 
dissolve faster than the powder44. However, disruption of lyophilized cake structure may not 
be the only destabilizing mechanism. Vibrational forces, or local heating effects generated 
from shaking itself, can potentially increase the contact area of powder particles allowing 
increased interactions between them45 leading to a cohesive powder that is “sticky.”46
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These differences in reconstitution time did not change, however, when the samples were 
reconstituted at different rates and with different diluents. While this lyophilized protein 
formulation had a relatively short reconstitution time, for other lyophilized protein samples 
in which the reconstitution time is longer and may be problematic during clinical 
administration, techniques mentioned by Cao et al15 could be beneficial. For example, 
reconstituting under vacuum, adding wetting agents, and/or using low diluent volumes were 
observed to be methods that can decrease reconstitution times in a high concentration 
lyophilized formulation of a Fc-fusion protein15. Additionally, three reconstitution 
procedures were described, in which the reconstitution medium is added and the vial is 
gently swirled for different periods of time, resulting in different reconstitution times15. In 
addition to reconstitution time, such reconstitution procedures could be evaluated in the 
future to assess their ability to minimize subvisible particle formation during reconstitution 
of shake stressed lyophilized protein powders.
Storage of Shake-stressed Lyophilized mAb Samples
The effects of the extent of shaking stress on subsequent storage stability of the freeze dried 
IgG1 formulation were also analyzed in this work. Lyophilized mAb samples were prepared 
as follows: (1) unstressed, physically intact cakes, (2) brief shaking (2.5 min) resulting in 
some cake breakage, and (3) extensive shaking (24 h) resulting in the cake being broken 
down to a powder. These samples were stored at different temperatures over a three month 
period, and at each time point, were reconstituted rapidly with 5 mL of water. Increasing 
shaking stress on the freeze dried cake showed some small differences with increased levels 
in turbidity and subvisible particles. Solution turbidity and subvisible particle concentration 
increased with increasing storage (T=0 < T=1 month <T=3months), especially for the 
samples stored at 40°C and 55°C. Similar to Schersch et al19-21, we also noticed a color 
change during storage of the lyophilized protein at higher temperatures in this formulation, 
which they reasonably attributed to the well-known non-enzymatic browning (Malliard-
type) reaction between reducing end sugars (potentially due to degraded sucrose) and lysine 
residues in the protein. The turbidity levels and subvisible particle concentrations are highest 
for the 24h shaken samples compared to the intact and 2.5 min shaken samples (Intact ∼ 2.5 
min shaking < 24 h shaking). Even though Figures 8A and 8B show increasing turbidity and 
particle counts with increasing shaking duration, storage time, and temperature, comparing 
samples to appropriate controls provides fuller understanding of the importance of shaking 
stress in inducing turbidity and micron particle formation. Figure 8C and Figure 8D compare 
a particular sample with its relevant control (T=0). Within each shaking time, higher 
temperatures and longer storage show increase in turbidity and particle counts relative to the 
control (4°C < 40°C < 55°C and T=0 ∼ T=1 month < T=3 months). When different shake 
times are compared, however, both turbidity and micron particle counts stay relatively 
constant or decrease, especially for the samples stored at 55°C for three months. This is 
largely because the controls themselves (T=0) increase in both turbidity and particle counts 
with increasing shaking duration so the instability associated with storage temperature and 
storage duration appear less profound.
In comparison, Schersch et al. have examined the effect of cake collapse (due to a variety of 
causes) during freeze-drying and subsequent storage at elevated temperatures on the stability 
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of a different IgG1 mAb.19-21 For example, when lyophilized cakes were collapsed by using 
different amounts of excipients or by using different freeze-drying protocols, the stability of 
protein in the collapsed and non-collapsed cakes were not different from one another. In 
addition, conformational integrity of the IgG1, as measured by FTIR analysis of the overall 
secondary structure, was also not affected by cake collapse.19 Additionally, when the effect 
of cake collapse on long-term storage at various temperatures ranging from 2-50°C up to 6 
months was analyzed, protein stability was retained in the collapsed and non-collapsed cakes 
after storage.20 In addition, the stability of the freeze-dried samples that were collapsed 
during freeze-drying vs. samples collapsed only during subsequent storage at 40 and 50°C 
for 3 months were compared to determine if the method of collapse affected protein 
stability. In this case, the stability of the protein in the collapsed lyophilized cakes (collapse 
due to freeze-drying) was better than the stability of protein in the storage-collapsed 
samples. Overall, the authors concluded that the collapse (freeze-dried) samples appeared to 
be more stable than the collapsed (storage) samples.21
The method of cake collapse could be another important parameter to consider as well in 
terms of effects on storage stability. In this work, we mechanically stressed the samples to 
alter the cake integrity to different extents and then stored the cakes (with varying levels of 
physical collapse) at different temperatures. In comparison, Schersch et al. have examined in 
detail the effect of different methods of cake collapse on the stability of a different IgG 
mAb.19-21 The stability of the samples collapsed during freeze-drying compared to samples 
during subsequent storage at elevated temperatures showed that the stability of the protein in 
the freeze-drying collapsed cake was better than the protein in the storage-collapsed 
samples. Overall, the authors concluded that the collapse (freeze-dried) samples appeared to 
be more stable than the collapsed (storage) samples21.
Conclusions
This case study highlights that post-lyophilization mechanical stresses, potentially 
encountered during shipping and transportation excursions, can result in physical instability 
of a lyophilized protein upon reconstitution. For this particular IgG1 mAb formulation, a 
liquid dosage form (5 mL of a 30 mg/mL protein solution in a 20 mL stoppered glass vial) 
showed instability due to shaking stress, despite the presence of stabilizers including 
polysorbate 80. The common sense approach of lyophilization did not successfully address 
the issue since the lyophilized dosage form of the same formulation was also shake-
sensitive. The increase in subvisible particle formation seen with the shake-stressed 
lyophilized IgG1 mAb upon reconstitution correlated with the formation of a finer powder 
and increased dissolution times, while no major differences in the structural integrity of the 
protein within the particles was noted. Thus, local differences in protein and excipient 
concentrations, upon the wetting and dissolution of the shake-stressed vs. control lyophilized 
cakes, likely contribute to these observations.
It is acknowledged that the level of shake stress that the cakes were exposed to in this study 
was relatively high, but this was a useful means of rapidly characterizing various conditions 
with respect to product quality impact (e.g., cake moisture, reconstitution rate, medium type, 
etc). The level of mechanical stress that a product will be exposed to during typical shipping 
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and handling can be variable, and it is easier to interpret their effects by comparing to 
stressed, worst-case study designs. In addition, within the general ASTM shipping guidance 
documents25, which are not specific for pharmaceutical products, the level of stress these 
documents suggest may be relatively high based on the schedule rating a user chooses to 
analyze.
The observations highlight the importance of considering shake sensitivity of lyophilized 
cakes in terms of protein stability as part of formulation development activities including the 
formulation composition, lyophilization process and reconstitution medium selection. 
Potential degradation is expected to be manageable by implementing an appropriate 
packaging and shipping configuration that will minimize or prevent extensive cake 
breakage. The use of orthogonal subvisible particle counting and sizing techniques such as 
light obscuration (HIAC) and/or coulter counters are suggested for future work for 
comparison to the MFI analytical results. Additional work is also required to further 
elucidate the nature of the physical degradation pathway(s) leading to protein particle 
formation during reconstitution of shake-stressed lyophilized mAb preparations, as well as 
to evaluate how this physical instability may vary with different IgG mAbs, other proteins 
and in the presence of different excipients and stabilizers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Physical instability of an IgG1 mAb formulation after shaking in the solid (freeze-dried 
cake) or liquid state for 5 min, 2h, 6h, and 15h. Samples were monitored by (A) solution 
turbidity and (B) total concentration of subvisible particles (≥2 μm as measured by MFI). 
Lyophilized samples were reconstituted prior to analysis. Each graph represents the average 
of three separate experiments (n=3) and error bars represent one standard deviation. Placebo 
samples were measured after 15 h of shaking showed negligible turbidity and concentration 
of micron sized particles compared to the protein containing samples.
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Physical instability of a lyophilized IgG1 mAb samples prepared with 0.6% and 6.8% 
moisture content and shake-stressed for 24 h in the solid state. Samples were reconstituted 
with water and monitored for solution turbidity (left Y- axis) and subvisible particles by 
MFI (right Y-axis). Placebo samples were measured after 24 h of shaking and showed 
negligible turbidity and concentration of micron sized particles compared to the protein 
containing samples. The graph represents the average of three separate experiments (n=3) 
and error bars represent one standard deviation.
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Radar plot analysis of MFI particle concentration and size distribution results before and 
after shake-stressing lyophilized mAb samples. IgG1 mAb lyophilized samples were 
prepared with 0.6% and 6.8% moisture content, shake-stressed for 24 h, reconstituted with 
water, and subvisible particle levels were measured by MFI (See Figure 2). The “particle # 
scale” radar plot shows actual particle concentration values in different size ranges and the 
“normalized scale” radar plot shows relative change in subvisible particle concentration and 
size distribution of shake stressed samples compared to the corresponding T=0 sample 
(unstressed control).
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Representative second-derivative FTIR spectra of protein particles isolated from lyophilized 
IgG1 mAb samples containing 0.6% and 6.8% moisture levels after shake-stress. Samples 
include: native, unstressed protein in solution (T=0); protein particles isolated from shake 
stressed lyophilized mAb (a) 0.6% and b) 6.8% moisture) after reconstitution (T=24h); and 
particles isolated from mAb solution heated at 80°C for 20 min (heat control). The 
characteristic peaks in the Amide I region indicative of intra and inter molecular beta sheet 
secondary structure are shown in the table. Values in table represent the average of three 
separate experiments (n=3) along with one standard deviation.
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Effect of reconstitution medium and addition rate on the physical instability of a lyophilized 
IgG1 mAb samples reconstituted after shaking. Lyophilized IgG1 mAb samples were shake-
stressed for 24 h and reconstituted slow (5 mL over 2.5 minutes) or fast (5 mL over 10 
seconds) conditions with the following mediums: (1) deionized H20, (2) 150 mM NaCl, (3) 
150 mM NaCl containing 0.05% polysorbate 80, and (4) 500 mM NaCl. The resulting (A) 
solution turbidity and (B) total concentration of subvisible particles (≥2 μm as measured by 
MFI) values are shown. Each graph represents the average of three separate experiments 
(n=3) and error bars represent one standard deviation.
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Radar plot analysis of MFI particle concentration and size distribution results as a function 
of the rate of reconstitution of shaking-stressed lyophilized mAb samples. Lyophilized IgG1 
mAb samples (without shaking, T=0) and 24 h of shaking (T=24) were reconstituted with 
deionized H20 slowly (5 mL over 2.5 min) or rapidly (5 mL over 10 s) are shown. The 
“particle # scale” radar plot shows actual particle concentration values in different size 
ranges and the “normalized scale” radar plot shows relative change in subvisible particle 
concentration and size distribution of shake stressed samples compared to the corresponding 
T=0 sample (unstressed control).
Telikepalli et al. Page 24























Radar plot analysis of MFI particle concentration and size distribution results as a function 
of diluent type used to reconstitute shake-stressed lyophilized mAb samples. Lyophilized 
IgG1 mAb samples (without shaking, T=0) and 24 hours of shaking (T=24) were 
reconstituted with various mediums under slow (5 mL over 2.5 min) or fast (5 mL over 10 s) 
conditions as indicated in the figure. Reconstitution diluents included: (1) 5 mL of 150 mM 
NaCl, (2) 5 mL of 150mM NaCl + 0.05% Polysorbate 80, and (3) 5 mL 500 mM NaCl. The 
“particle # scale” radar plot shows actual particle concentration values in different size 
ranges and the “normalized scale” radar plot shows relative change in subvisible particle 
concentration and size distribution of shake stressed samples compared to the corresponding 
T=0 sample (unstressed control).
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Storage stability of lyophilized IgG1 mAb samples as a function of cake integrity. 
Lyophilized samples included unstressed control (Intact cake), shake stressed for 2.5 min, 
and shake stressed for 24 hrs. Representative pictures of intact cake, 2.5 min shaking, and 
24h shake stressed cakes at time zero are shown. Samples were then stored for up to 3 
months at three different temperatures (4, 40, 55°C), reconstituted and monitored for (A) 
solution turbidity and (B) total concentration of subvisible particles (≥2 μm as measured by 
MFI). Stressed samples, which have been shaken for a certain amount of time and stored at 
different temperatures, were compared to controls (T=0, but with shaking) and resulting C) 
normalized turbidity or D) normalized subvisible particle concentrations are shown. The y-
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axis values for both (C) and (D) were obtained by dividing the turbidity values (or micron 
particle concentration) of a stored sample by its relevant control at time zero experiencing 
similar duration of shaking. Each graph represents the average of three separate experiments 
(n=3) and error bars represent one standard deviation. Placebo samples were measured after 
3 months storage at 55°C h and showed low turbidity (∼1 NTU) and a relatively low 
number of micron sized particles (∼12,000 particles/mL).
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